Abstract
We studied changes in the contents of the transcription factors NF-kB and Fos, the apoptosis regulating factors bax and bcl-xl, and a marker of astroglial activity, viz., the glial fibrillar acidic protein, in the spinal cords of rats with experimental streptozotocin-induced diabetes. We found that shifts in the levels of these factors after induction of diabetes may be partially prevented by administration of the protein kinase C (PKC) inhibitors chelerythrine hydrochloride and rottlerin. Our data show that these substances are promising drugs for the correction of diabetic neuropathy. PKC isoenzymes contribute to pathogenesis of diabetic neuropathy differently; therefore, the development of selective inhibitors for specific PKC isoenzymes may improve their efficacy and decrease the probability of the appearance of side effects.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
